ONE plug About us Products Pipeline Partners sustainability Investor Media OREXO INVESTOR FINANCIAL CALENDAR & EVENT Interim report Q3, 2017 2017-10-19 Date of publication 2017-10-19 Time of publication 8.00 CET AudioCast & Q&A 14.00 CET ir@orexo.com For those who do not have the opportunity to participate in the Webcast, please email questions no later than the same day at 11.00 CET Phone number to participate in the AudioCast Not yet available Link AudioCast Not yet available Presentation Downloadable under Investors / Reports, Presentations & AudioCasts about an hour before the AudioCast starts Our Drug Delivery technologies improve medicines PO Box 303. SE-751 05 Uppsala, Sweden Tel. +46 (0) 18 780 88 00 info@orexo.com © 2017 Orexo AB (publ) - All rights reserved Contact | Glossary & Definitions | Privacy Policy Orexo US

ONE plug About us Products Pipeline Partners sustainability Investor Media OREXO PARTNERS Our partners are an important key to success Orexo has extensive experience of successful partnerships. Through our collaborations, we have enabled the development and launch of unique products, which has improved the treatment options for patients all over the world. We are constantly looking for new potential partners to build our business and meet our goals. In-licensing of products, technologies and development projects, which complements our commercial strategy, as well as out-licensing of our innovative projects are of the highest priority. Development of next-generation drugs 11 JULY 2017 - As a result of the work of developing the next generation of Drug Delivery technologies, we have now started a new project, OX382, which is an innovative oral formulation. OX382 is scheduled to be included in Phase 1 clinical trials within six to nine months. READ MORE Charlotta Liljebris Senior Director Corporate Development Tel: +46 70 339 15 34 charlotta.liljebris@orexo.com Our Drug Delivery technologies improve medicines PO Box 303. SE-751 05 Uppsala, Sweden Tel. +46 (0) 18 780 88 00 info@orexo.com © 2017 Orexo AB (publ) - All rights reserved Contact | Glossary & Definitions | Privacy Policy Orexo US